Norway's $2.3 trillion sovereign wealth fund, the world's largest single stock market investor, has expressed significant concern over what it perceives as a steady erosion of shareholder rights across major global markets. The fund, which invests the Norwegian state's oil and gas revenues and owns approximately 1.5% of all listed companies globally, highlighted that regulations are increasingly favoring company founders and insiders over independent investors. Carine Smith Ihenacho, the fund's chief governance and compliance officer, noted this trend is observable not just in the U.S., but also in the UK, Europe, and Hong Kong.

A primary concern raised by the fund is the proliferation of dual-share classes, which grant founders and insiders disproportionately stronger voting rights compared to standard shares held by independent investors. Additionally, the fund is troubled by changes in reporting requirements, which are becoming more voluntary, and restrictions on shareholders' ability to sue companies and their boards. Fund CEO Nicolai Tangen attributed this trend partly to increased competition among stock exchanges to attract new IPOs, leading them to permit greater deviations from traditional corporate governance norms.

While dual-share classes are argued by supporters to allow founders to pursue long-term strategies, critics contend that concentrated voting power reduces accountability and limits the ability of other shareholders to challenge management decisions. The fund emphasized the importance of "guardrails" around founders' voting rights, such as sunset clauses, to mitigate these risks. Despite these concerns, the fund recently disclosed a $1.22 billion stake in Elon Musk's SpaceX, where Musk holds over 80% of voting rights and combines key leadership roles, raising further questions about governance. The fund is actively advocating with stock exchanges, regulators, and companies to counter this erosion of shareholder rights, viewing it as crucial for informed investment decisions and risk assessment.